Lux Co-invest Opportunities, L.p. - Net Worth and Insider Trading

Lux Co-invest Opportunities, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lux Co-invest Opportunities, L.p. owns 6 companies in total, including Recursion Pharmaceuticals Inc (RXRX) , Aeva Technologies Inc (AEVA) , and Science 37 Holdings Inc (SNCE) among others .

Click here to see the complete history of Lux Co-invest Opportunities, L.p.’s form 4 insider trades.

Insider Ownership Summary of Lux Co-invest Opportunities, L.p.

Ticker Comapny Transaction Date Type of Owner
RXRX Recursion Pharmaceuticals Inc 2021-12-07 other: Former 10% Owner
AEVA Aeva Technologies Inc 2021-03-12 10 percent owner
SNCE Science 37 Holdings Inc 2021-10-06 10 percent owner
2021-07-22 10 percent owner
2021-06-04 10 percent owner
2021-06-04 10 percent owner

Lux Co-invest Opportunities, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lux Co-invest Opportunities, L.p. Ownership Network

Ownership Network List of Lux Co-invest Opportunities, L.p.

No Data

Ownership Network Relation of Lux Co-invest Opportunities, L.p.


Lux Co-invest Opportunities, L.p. Owned Company Details

What does Recursion Pharmaceuticals Inc do?

Who are the key executives at Recursion Pharmaceuticals Inc?

Lux Co-invest Opportunities, L.p. is the other: Former 10% Owner of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Christopher Gibson , President and COO Tina Marriott Larson , and Chief Financial Officer Michael Secora .

Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary

Over the past 18 months, Lux Co-invest Opportunities, L.p. made no insider transaction in Recursion Pharmaceuticals Inc (RXRX). Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 456,504 shares made by Blake Borgeson , a net sale of 1,204,278 shares made by Christopher Gibson , and a net sale of 85,000 shares made by Tina Marriott Larson .

In summary, during the past 3 months, insiders sold 559,946 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 559,946 shares. During the past 18 months, 2,800,166 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 1,398,309 shares were bought by its insiders, resulting in a net sale of 1,401,857 shares.

Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Recursion Pharmaceuticals Inc Insider Transactions

No Available Data

Lux Co-invest Opportunities, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Lux Co-invest Opportunities, L.p.. You might contact Lux Co-invest Opportunities, L.p. via mailing address: C/o Lux Capital Management, 920 Broadway, 11th Floor, New York Ny 10010.

Discussions on Lux Co-invest Opportunities, L.p.

No discussions yet.